These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2979064)
41. In vitro and in vivo comparison of a randomly coupled antibody fragment-enzyme conjugate with a site-specific conjugate. Werlen RC; Offord RE; Blakey DC; East SJ; Melton RG; Rose K Biomed Pept Proteins Nucleic Acids; 1995; 1(5):251-4. PubMed ID: 9575348 [TBL] [Abstract][Full Text] [Related]
42. Applicability of monoclonal antibody Fab fragments as a carrier of neocarzinostatin in targeting chemotherapy. Otsuji E; Yamaguchi T; Tsuruta H; Yata Y; Nishi H; Okamoto K; Taniguchi K; Kato M; Kotani T; Kitamura K; Takahashi T J Surg Oncol; 1996 Feb; 61(2):149-54. PubMed ID: 8606548 [TBL] [Abstract][Full Text] [Related]
47. Targeting of liposomes to tumor cells in vivo. Papahadjopoulos D; Gabizon A Ann N Y Acad Sci; 1987; 507():64-74. PubMed ID: 3327419 [No Abstract] [Full Text] [Related]
48. Limitations of the human tumour xenograft system in individual patient drug sensitivity testing. Bailey MJ; Jones AJ; Shorthouse AJ; Raghaven D; Selby P; Gibbs J; Peckham MJ Br J Cancer; 1984 Nov; 50(5):721-4. PubMed ID: 6498071 [No Abstract] [Full Text] [Related]
49. The effect of combined irradiation and chemotherapy on cancer growth with special reference to studies with folic acid analogues. LOKEN MK; KIM YS; MOSSER DG; MARVIN JF Radiology; 1959 Aug; 73():166-74. PubMed ID: 14418029 [No Abstract] [Full Text] [Related]
50. Growth curves of human cancer transplants during experimental chemotherapy. FRIEDELL GH; SHERMAN JD; SOMMERS SC Cancer; 1961; 14():1117-21. PubMed ID: 13701957 [No Abstract] [Full Text] [Related]
53. Variation in resistance patterns in different neoplasms. POTTER M Ann N Y Acad Sci; 1958 Dec; 76(3):630-42. PubMed ID: 13627890 [No Abstract] [Full Text] [Related]
54. Immunotoxins: status and prospects. Spooner RA; Lord JM Trends Biotechnol; 1990 Jul; 8(7):189-93. PubMed ID: 1366624 [TBL] [Abstract][Full Text] [Related]
56. Targeting enzyme albumin conjugates. Examining the magic bullet. Poznansky MJ Ann N Y Acad Sci; 1987; 507():211-9. PubMed ID: 3327414 [No Abstract] [Full Text] [Related]
57. An evaluation of teropterin therapy in metastatic neoplasms. WEINTRAUB S; ARONS I; WRIGHT LT; ANDLER LR; PRIGOT A; WRIGHT JC; LEHV SP Acta Unio Int Contra Cancrum; 1953; 9(1):119-25. PubMed ID: 13057686 [No Abstract] [Full Text] [Related]
58. The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer. Pietersz GA Bioconjug Chem; 1990; 1(2):89-95. PubMed ID: 2095213 [No Abstract] [Full Text] [Related]
59. [Effect of teropterin on Walker tumors]. ESER G Tip Fak Mecm; 1951; 14(2):334-6. PubMed ID: 14942834 [No Abstract] [Full Text] [Related]
60. Synthesis of site-specific methotrexate-IgG conjugates. Comparison of stability and antitumor activity with active-ester-based conjugates. Kralovec J; Singh M; Mammen M; Blair AH; Ghose T Cancer Immunol Immunother; 1989; 29(4):293-302. PubMed ID: 2787696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]